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Toward a Better Understanding of...

Identifying Novel Epigenetic Dependencies in
Pre-Leukemic Hematopoietic Stem Cells
Emily Haussler
Mentor: Grant Challen
The DNA methylation modifying enzymes DNMT3A and TET2 are essential for proper
differentiation of hematopoietic stem cells and are frequently found to be mutated in
blood cancers. Although their functions in regulating DNA methylation have been
characterized, a specific connection between methylation patterns and altered gene
expression has not been established to explain the observed disease phenotype. We
hypothesize that Dnmt3a and Tet2 mutant HSCs are dependent on other epigenetic
regulators to corrupt normal hematopoietic pathways. If this is the case, inhibition of
the chromatin modifiers on which driver mutations Dnmt3a and Tet2 depend could
represent a novel therapeutic strategy for reducing the propagation of pre-leukemic
HSC populations and preventing the onset of hematological malignancies. To test
this hypothesis, we employed a CRISPR-Cas9 based negative selection screen on cells
derived from DNMT3A-null and TET2-null HSCs, targeting 180 chromatin modifying
genes. Results were obtained from three biological replicates, and those genes showing
significant fold depletion over time in Dnmt3a-null or Tet2-null cells were selected
for further investigation as potential therapeutic targets. Specifically, Esco1, Brd2
and Zmynd8 are being considered for future directions. Ultimately, we conclude that
our negative selection CRISPR screen is optimized to detect those genes potentially
showing an epigenetic dependence with DNMT3A and TET2 in hematopoiesis, and that
functional studies in vivo are needed to validate and further define our in vitro findings.
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